Daratumumab in combination with urelumab to potentiate anti-myeloma activity in lymphocyte-deficient mice reconstituted with human NK cells
about
Daratumumab in combination with urelumab to potentiate anti-myeloma activity in lymphocyte-deficient mice reconstituted with human NK cells
description
2019 nî lūn-bûn
@nan
2019年の論文
@ja
2019年学术文章
@wuu
2019年学术文章
@zh
2019年学术文章
@zh-cn
2019年学术文章
@zh-hans
2019年学术文章
@zh-my
2019年学术文章
@zh-sg
2019年學術文章
@yue
2019年學術文章
@zh-hant
name
Daratumumab in combination wit ...... onstituted with human NK cells
@en
type
label
Daratumumab in combination wit ...... onstituted with human NK cells
@en
prefLabel
Daratumumab in combination wit ...... onstituted with human NK cells
@en
P2093
P50
P1433
P1476
Daratumumab in combination wit ...... onstituted with human NK cells
@en
P2093
Aintzane Zabaleta
Ascension Lopez
Aura Muntasell
Bruno Paiva
Diego Alignani
Guiomar Perez
Ignacio Melero
Inmaculada Rodriguez
Luna Minute
Miguel F Sanmamed
P304
P356
10.1080/2162402X.2019.1599636
P577
2019-04-13T00:00:00Z